T1	Outcomes 146 154	efficacy
T2	Outcomes 159 165	safety
T3	Outcomes 806 845	overall progression-free survival rates
T4	Outcomes 895 917	overall response rates
T5	Outcomes 986 1015	Median overall survival times
T6	Outcomes 1175 1200	progression-free survival
T7	Outcomes 1278 1294	overall survival
T8	Outcomes 1522 1549	Severe hematologic toxicity
T9	Outcomes 1647 1690	growth factor or blood product utilization.
T10	Outcomes 1717 1725	efficacy
T11	Outcomes 1737 1743	safety
